Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|June 17, 2025
Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in MiceJulia Kronberger, Theresa Balber, Hemma Schueffl, et al.
Molecular Pharmaceutics|July 24, 2015
Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission TomographyThomas Wanek, Kerstin Römermann, Severin Mairinger, et al.
Molecular Pharmaceutics|December 3, 2019
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [11C]Tariquidar and PET in Humans and MiceIrene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, et al.
EMBO Molecular Medicine|October 27, 2018
EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signalingMarkus Linder, Elisabeth Glitzner, Sriram Srivatsa, et al.
Nuclear Medicine and Biology|May 15, 2007
Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMPMarkus Mitterhauser, Stefan Toegel, Wolfgang Wadsak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2015
[18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodentsDaniela Haeusler, Claudia Kuntner, Lukas Nics, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinibNicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Reproducibility and Comparability of Preclinical PET Imaging Data: A Multicenter Small-Animal PET StudyJulia G Mannheim, Martin Mamach, Sybille Reder, et al.
Molecular Imaging and Biology|June 21, 2024
Optimizing SUV Analysis: A Multicenter Study on Preclinical FDG-PET/CT Highlights the Impact of StandardizationClaudia Kuntner, Carlos Alcaide, Dimitris Anestis, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance proteinBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
Pageof 9